{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:23:25Z","timestamp":1792794205002,"version":"4.5.0"},"reference-count":51,"publisher":"American Physiological Society","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK135644"],"award-info":[{"award-number":["R01 DK135644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK129227"],"award-info":[{"award-number":["R01 DK129227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL160529"],"award-info":[{"award-number":["T32 HL160529"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Veteran Affairs","award":["I01 BX004024"],"award-info":[{"award-number":["I01 BX004024"]}],"id":[{"id":"https:\/\/ror.org\/05rsv9s98","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20POST35180224"],"award-info":[{"award-number":["20POST35180224"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["TPA3549003"],"award-info":[{"award-number":["TPA3549003"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Veterans Affairs or the United States Government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Opioid use for pain management and illicit consumption has been associated with adverse cardiovascular and cardiorenal outcomes. Despite these associations, the mechanisms underlying opioid-induced kidney damage remain poorly understood. Recently, we demonstrated that stimulation of kappa opioid receptors (KOR) is implicated in the aggravation of salt-sensitive hypertension, glomerular injury, and podocyte damage through excessive podocyte calcium influx. This study aims to elucidate the KOR signaling and renal outcomes underlying opioid use in Sprague-Dawley (SD) rats. Here, we employed freshly isolated glomeruli from SD male rats and immortalized human podocyte cell cultures to investigate the role of KORs in podocyte calcium regulation and overall glomerular function. A glomerular permeability assay was used to evaluate the impact of KORs on glomerular filter integrity. Additionally, the long-term effects of KOR activation were assessed in vivo by chronic intravenous infusion of selective KOR agonist BRL 52537 in SD rats. We found that acute application of BRL 52537 resulted in increased plasma membrane ion channel activity in immortalized human podocytes. Significant calcium influx in response to BRL 52537 was detected in podocytes of the isolated SD rat glomeruli. Further, glomerular permeability analysis revealed increased permeability and impaired filter integrity, indicating altered glomerular function. Lastly, prolonged KOR activation in SD rats results in an increase in blood pressure, an elevation of basal calcium levels in podocytes, and albuminuria. In conclusion, this study identifies novel renal physiological mechanisms through which opioid-induced KOR activation contributes to podocyte injury and glomerular damage in SD rats.<\/jats:p>","DOI":"10.1093\/function\/zqaf028","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T07:53:46Z","timestamp":1751097226000},"source":"Crossref","is-referenced-by-count":4,"title":["Renal Implications of Kappa Opioid Receptor Signaling in Sprague-Dawley Rats"],"prefix":"10.1152","volume":"6","author":[{"given":"Steven","family":"Didik","sequence":"first","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]},{"name":"James A. Haley Veterans Hospital , Tampa, FL 33612 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Golosova","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin Department of Physiology, , Milwaukee, WI 53226 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Zietara","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Bohovyk","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Ahrari","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Levchenko","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olha","family":"Kravtsova","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish","family":"Taneja","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Khedr","sequence":"additional","affiliation":[{"name":"Ain-Shams University Department of Physiology, , Cairo ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marharyta","family":"Semenikhina","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina Division of Nephrology, Department of Medicine, , Charleston , SC 29425 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-5527","authenticated-orcid":false,"given":"Oleg","family":"Palygin","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina Division of Nephrology, Department of Medicine, , Charleston , SC 29425 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-8356","authenticated-orcid":false,"given":"Alexander","family":"Staruschenko","sequence":"additional","affiliation":[{"name":"University of South Florida Department of Molecular Pharmacology and Physiology, , Tampa, FL 33602 ,","place":["USA"]},{"name":"James A. Haley Veterans Hospital , Tampa, FL 33612 ,","place":["USA"]},{"name":"University of South Florida Hypertension and Kidney Research Center, , Tampa, FL 33602 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2025080113571260900_bib1","doi-asserted-by":"publisher","DOI":"10.3386\/w28067","article-title":"Economic studies on the opioid crisis: a review","author":"Maclean","year":"2020"},{"issue":"1","key":"2025080113571260900_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semnephrol.2021.02.001","article-title":"Pharmacologic considerations for opioid use in kidney disease","volume":"41","author":"Hawley","year":"2021","journal-title":"Semin Nephrol"},{"issue":"2","key":"2025080113571260900_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2020.11.002","article-title":"Cardiovascular complications of opioid use: JACC state-of-the-art review","volume":"77","author":"Krantz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2025080113571260900_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2165\/00003088-199631060-00002","article-title":"Pharmacokinetics of opioids in renal dysfunction","volume":"31","author":"Davies","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2025080113571260900_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jhm.2102","article-title":"Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals","volume":"9","author":"Herzig","year":"2014","journal-title":"J Hosp Med"},{"issue":"6","key":"2025080113571260900_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1440-1797.2012.01619.x","article-title":"Podocyte culture: tricks of the trade","volume":"17","author":"Ni","year":"2012","journal-title":"Nephrology"},{"issue":"9","key":"2025080113571260900_bib7","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.3390\/ijms22094396","article-title":"Cytoskeleton rearrangements modulate TRPC6 channel activity in podocytes","volume":"22","author":"Shalygin","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2025080113571260900_bib8","doi-asserted-by":"crossref","first-page":"F1450","DOI":"10.1152\/ajprenal.00246.2019","article-title":"Progression of diabetic kidney disease in T2DN rats","volume":"317","author":"Palygin","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2025080113571260900_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00441-013-1710-y","article-title":"Arp2\/3 complex inhibitors adversely affect actin cytoskeleton remodeling in the cultured murine kidney collecting duct M-1 cells","volume":"354","author":"Ilatovskaya","year":"2013","journal-title":"Cell Tissue Res"},{"issue":"10","key":"2025080113571260900_bib10","doi-asserted-by":"crossref","first-page":"C1050","DOI":"10.1152\/ajpcell.00138.2013","article-title":"Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli","volume":"305","author":"Ilatovskaya","year":"2013","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"100","key":"2025080113571260900_bib11","first-page":"e52850","article-title":"Single-channel analysis and calcium imaging in the podocytes of the freshly isolated glomeruli","volume":"92","author":"Ilatovskaya","year":"2015","journal-title":"J Vis Exp"},{"issue":"7","key":"2025080113571260900_bib12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2018030280","article-title":"A NOX4\/TRPC6 pathway in podocyte calcium regulation and renal damage in diabetic kidney disease","volume":"29","author":"Ilatovskaya","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2025080113571260900_bib13","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1152\/ajprenal.00466.2016","article-title":"Intravital imaging of the kidney in a rat model of salt-sensitive hypertension","volume":"313","author":"Endres","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2025080113571260900_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41598-017-00406-2","article-title":"The role of angiotensin II in glomerular volume dynamics and podocyte calcium handling","volume":"7","author":"Ilatovskaya","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"2025080113571260900_bib15","doi-asserted-by":"crossref","first-page":"F1049","DOI":"10.1152\/ajprenal.00311.2015","article-title":"Fluorescence dilution technique for measurement of albumin reflection coefficient in isolated glomeruli","volume":"309","author":"Fan","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7539","key":"2025080113571260900_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes","volume":"518","author":"Kundaje","year":"2015","journal-title":"Nature"},{"issue":"12","key":"2025080113571260900_bib17","doi-asserted-by":"crossref","first-page":"e81812","DOI":"10.1371\/journal.pone.0081812","article-title":"A novel source of cultured podocytes","volume":"8","author":"Da\u00a0Sacco","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2025080113571260900_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2025080113571260900_bib19","first-page":"139","article-title":"The mechanisms of calcium-mediated cell injury and cell death","volume":"4","author":"Trump","year":"1996","journal-title":"New Horiz"},{"issue":"7","key":"2025080113571260900_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00467-012-2335-1","article-title":"Proteinuria and progression of glomerular diseases","volume":"28","author":"Erkan","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2025080113571260900_bib21","doi-asserted-by":"crossref","first-page":"546039","DOI":"10.1155\/2012\/546039","article-title":"Understanding the mechanisms of proteinuria: therapeutic implications","volume":"2012","author":"Toblli","year":"2012","journal-title":"Int J Nephrol"},{"issue":"1","key":"2025080113571260900_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/ijms18010223","article-title":"What do we know about opioids and the kidney?","volume":"18","author":"Mallappallil","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2025080113571260900_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrcardio.2013.159","article-title":"Effects of opium consumption on cardiometabolic diseases","volume":"10","author":"Masoudkabir","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2025080113571260900_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/cs0750071","article-title":"Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbits","volume":"75","author":"May","year":"1988","journal-title":"Clin Sci"},{"issue":"1","key":"2025080113571260900_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1152\/physrev.00013.2022","article-title":"Ion channels and channelopathies in glomeruli","volume":"103","author":"Staruschenko","year":"2023","journal-title":"Physiol Rev"},{"issue":"8","key":"2025080113571260900_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41581-024-00835-z","article-title":"Calcium signalling and transport in the kidney","volume":"20","author":"Staruschenko","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2025080113571260900_bib27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jpp\/rgac014","article-title":"Attenuation of opioid tolerance by ETA receptor antagonist, BQ123, administered intravenously in mice","volume":"74","author":"Bhalla","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"2025080113571260900_bib28","first-page":"341","volume-title":"Call to Action: Opioid Crisis Impacting More than Just Patients","author":"Kovacs","year":"2020"},{"issue":"1","key":"2025080113571260900_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2025080113571260900_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2215\/CJN.00300106","article-title":"Chronic nephropathies of cocaine and heroin abuse: a critical review","volume":"1","author":"Jaffe","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2025080113571260900_bib31","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.34067\/KID.0000000000000291","article-title":"Opioids and the kidney: a compendium","volume":"4","author":"Didik","year":"2023","journal-title":"Kidney360"},{"issue":"3","key":"2025080113571260900_bib32","doi-asserted-by":"crossref","first-page":"e55748","DOI":"10.1371\/journal.pone.0055748","article-title":"Morphine induces albuminuria by compromising podocyte integrity","volume":"8","author":"Lan","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"2025080113571260900_bib33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ki.1989.264","article-title":"Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor","volume":"36","author":"Martin","year":"1989","journal-title":"Kidney Int"},{"issue":"6","key":"2025080113571260900_bib34","doi-asserted-by":"crossref","first-page":"F1388","DOI":"10.1152\/ajprenal.00389.2007","article-title":"Morphine induces mesangial cell proliferation and glomerulopathy via \u03ba-opioid receptors","volume":"294","author":"Weber","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2025080113571260900_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/HYPERTENSIONAHA.121.18503","article-title":"Nalfurafine, a G-protein-biased KOR (Kappa Opioid Receptor) agonist, enhances the diuretic response and limits electrolyte losses to standard-of-care diuretics","volume":"79","author":"Meariman","year":"2022","journal-title":"Hypertension"},{"issue":"12","key":"2025080113571260900_bib36","doi-asserted-by":"crossref","first-page":"e202000853","DOI":"10.26508\/lsa.202000853","article-title":"Role of opioid signaling in kidney damage during the development of salt-induced hypertension","volume":"3","author":"Golosova","year":"2020","journal-title":"Life Sci Alliance"},{"issue":"6","key":"2025080113571260900_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.kint.2023.01.016","article-title":"The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5","volume":"103","author":"Polat","year":"2023","journal-title":"Kidney Int"},{"issue":"5","key":"2025080113571260900_bib38","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1172\/JCI71702","article-title":"Intravital imaging of podocyte calcium in glomerular injury and disease","volume":"124","author":"Burford","year":"2014","journal-title":"J Clin Invest"},{"issue":"10","key":"2025080113571260900_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.31083\/j.fbl2810240","article-title":"The physiopathologic roles of calcium signaling in podocytes","volume":"28","author":"Tu","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"2025080113571260900_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0016-5085(95)90287-2","article-title":"Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention","volume":"109","author":"Bosch-Marce","year":"1995","journal-title":"Gastroenterology"},{"issue":"11","key":"2025080113571260900_bib41","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/j.1552-4604.1994.tb01991.x","article-title":"Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans","volume":"34","author":"Reece","year":"1994","journal-title":"J Clin Pharm"},{"issue":"5","key":"2025080113571260900_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2125.1991.tb03960.x","article-title":"Mechanism of diuretic action of spiradoline (U-62066E)\u2014a kappa opioid receptor agonist in the human","volume":"32","author":"Rimoy","year":"1991","journal-title":"Br J Clin Pharm"},{"issue":"1","key":"2025080113571260900_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5152\/balkanmedj.2013.9424","article-title":"Codeine-induced syndrome of inappropriate antidiuretic hormone: case report","volume":"33(","author":"Karahan","year":"2014","journal-title":"Balkan Med J"},{"issue":"6","key":"2025080113571260900_bib44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1515\/jpem-2017-0001","article-title":"Opioid-induced hyponatremia in a patient with central diabetes insipidus: independence from ADH","volume":"30","author":"Bhat","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2025080113571260900_bib45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2014030278","article-title":"A potential role for mechanical forces in the detachment of podocytes and the progression of CKD","volume":"26","author":"Kriz","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2025080113571260900_bib46","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/ndt\/gfs037","article-title":"Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension","volume":"27","author":"Palatini","year":"2012","journal-title":"Nephrol Dial Transp"},{"issue":"11","key":"2025080113571260900_bib47","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1681\/ASN.V12112280","article-title":"Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension","volume":"12","author":"Quaschning","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2025080113571260900_bib48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejpain.2005.12.001","article-title":"Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine","volume":"10","author":"Filitz","year":"2006","journal-title":"Eur J Pain"},{"issue":"3","key":"2025080113571260900_bib49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/bja\/64.3.276","article-title":"Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites","volume":"64","author":"Hand","year":"1990","journal-title":"Br J Anaesth"},{"issue":"5","key":"2025080113571260900_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ekir.2020.01.006","article-title":"Randomized controlled trial of Difelikefalin for chronic pruritus in hemodialysis patients","volume":"5","author":"Fishbane","year":"2020","journal-title":"Kidney Int R"},{"issue":"5","key":"2025080113571260900_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14656566.2020.1849142","article-title":"An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease","volume":"22","author":"Lipman","year":"2021","journal-title":"Expert Opin Pharmacother"}],"container-title":["Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.physiology.org\/doi\/full\/10.1093\/function\/zqaf028","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.physiology.org\/doi\/pdf\/10.1093\/function\/zqaf028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:07:21Z","timestamp":1781629641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.physiology.org\/doi\/full\/10.1093\/function\/zqaf028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/function\/zqaf028","relation":{},"ISSN":["2633-8823"],"issn-type":[{"value":"2633-8823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"zqaf028"}}